OR7E7P

Across TCGA pan-cancer cohorts, OR7E7P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated OR7E7P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR7E7P RNA is associated with better overall survival. In most high-consensus cancer types, elevated OR7E7P expression acts as an unfavorable survival marker, although some lineages such as HNSC and THYM show a favorable association.

HNSC, KIRC, and MESO are the cancer types where OR7E7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.464	0.321	.001	62	view →
KIRC	DFS	Median	IV	0.215	0.498	.001	60	view →
MESO	DFS	Tertile	II,III,IV	0.253	0.438	.003	55	view →
READ	DFS	Median	IV	0.402	0.794	.005	39	view →
KICH	DFS	Tertile	All	0.557	0.919	.004	36	view →
THYM	DFS	Median	All	0.965	0.659	.007	32	view →
STAD	DFS	Tertile	IV	0.297	0.699	.010	27	view →
CESC	OS	Median	II,III,IV	0.904	0.735	.007	24	view →
PAAD	DFS	Median	All	0.219	0.493	<.001	23	view →
THCA	DFS	Median	III,IV	0.239	0.883	.001	19	view →
SKCM	OS	Median	III,IV	0.773	0.631	.006	19	view →
ACC	DFS	Tertile	All	0.336	0.760	.021	17	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

OR7E7P–HNSC (OS)

Open the HNSC breakdown →